Home About us Contact | |||
Single Donor (single + donor)
Selected AbstractsA novel LCD (coal tar) solution for psoriasis does not discolor naturally light or color-processed hair in an exaggerated exposure test modelJOURNAL OF COSMETIC DERMATOLOGY, Issue 3 2009Colleen Johnson BS Summary Background, Scalp psoriasis is reported to occur in 50,80% of psoriasis sufferers. Treatment of scalp psoriasis requires special consideration of product esthetics and staining potential due to the presence of hair. Aim, To evaluate the potential of a new, marketed liquor carbonis distillate (LCD; coal tar) solution to discolor naturally light or color-processed hair under exaggerated exposure conditions. Methods, Samples of naturally light and color-processed hair from a single donor were exposed to LCD solution repeatedly over 14 days and via submergence for 24 h. Color of LCD-treated hair samples was compared with untreated control hair samples. Results, LCD solution did not discolor naturally light or color-processed hair following repeated exposures and 24 h submergence. Conclusion, The marketed LCD solution does not appear to discolor naturally light or color-processed hair. [source] Hole,polar phonon interaction scattering mobility in chain structured TlSe0.75S0.25 crystalsPHYSICA STATUS SOLIDI (A) APPLICATIONS AND MATERIALS SCIENCE, Issue 7 2009A. F. Qasrawi Abstract In this study, the electrical resistivity, charge carriers density and Hall mobility of chain structured TlSe0.75S0.25 crystal have been measured and analyzed to establish the dominant scattering mechanism in crystal. The data analyses have shown that this crystal exhibits an extrinsic p-type conduction. The temperature-dependent dark electrical resistivity analysis reflected the existence of three energy levels located at 280 meV, 68 meV and 48 meV. The temperature dependence of carrier density was analyzed by using the single donor,single acceptor model. The carrier concentration data were best reproduced assuming the existence of an acceptor impurity level being located at 68 meV consistent with that observed from resistivity measurement. The model allowed the determination of the hole effective mass and the acceptor,donor concentration difference as 0.44m0 and 2.2 × 1012 cm,3, respectively. The Hall mobility of the TlSe0.75S0.25 crystal is found to be limited by the scattering of charged carriers over the (chain) boundaries and the scattering of hole,polar phonon interactions above and below 300 K, respectively. The value of the energy barrier height at the chain boundaries was found to be 261 meV. The polar phonon scattering mobility revealed the high-frequency and static dielectric constants of 13.6 and 15.0, respectively. (© 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim) [source] The Life-Years Saved by a Deceased Organ DonorAMERICAN JOURNAL OF TRANSPLANTATION, Issue 9 2005Mark A. Schnitzler Understanding the additional life-years given to patients by deceased organ donors is necessary as substantial investments are being proposed to increase organ donation. Data were drawn from the Scientific Registry of Transplant Recipients. All patients placed on the wait-list as eligible to receive or receiving a deceased donor solid organ transplant between 1995 and 2002 were studied. The benefit of transplant was determined by the difference in the expected survival experiences of transplant recipients and candidates expecting transplant soon. An average organ donor provides 30.8 additional life-years distributed over an average 2.9 different solid organ transplant recipients, whereas utilization of all solid organs from a single donor provides 55.8 additional life-years spread over six organ transplant recipients. The relative contribution of the different organs to the overall life-year benefit is higher for liver, heart and kidney, and lowest for lung and pancreas. The life-year losses from unprocured and unused organs are comparable to suicide, congenital anomalies, homicide or perinatal conditions and half that of HIV. Approximately 250 000 additional life-years could be saved annually if consent for potential deceased donors could be increased to 100%. Therefore, increasing organ donation should be considered among our most important public health concerns. [source] Electron Donation in the Water,Water Hydrogen BondCHEMISTRY - A EUROPEAN JOURNAL, Issue 4 2009Rustam Donation is not from an sp3orbital: Decomposition analysis, based on absolutely localized molecular orbitals, provides an alternative and somewhat unconventional view of hydrogen bonding in the water dimer. A new description of the electron-donating orbital is uncovered:,unlike sp3 lone pairs, a single donor,acceptor orbital pair forms, in which the donating orbital changes its orientation according to the relative positions of the two molecules. [source] Donor,Acceptor Systems: Energy Transfer from CdS Quantum Dots/Rods to Nile Red DyeCHEMPHYSCHEM, Issue 14 2008Suparna Sadhu Abstract We demonstrate strong evidence of shape-dependent efficient resonance energy transfer between CdS quantum dots (QDs) and quantum rods (QRs) (donor) to Nile Red dye (acceptor). We also report a simple solution-based method for the preparation of high quality CdS QDs and CdS QRs at relatively low temperature. The observed quenching of PL intensities are 78.8,% and 63.8,% for CdS QDs and QRs, respectively in the presence of Nile Red dye. The calculated energy-transfer efficiencies are 45,% and 19,% from QDs and QRs to dyes, respectively. The energy transfer varies with changing the shape of the nanoparticles. The estimated Förster distances (R0) are 37.8 and 33.8 Å for CdS QDs and QRs, respectively. In the present study, the estimated distances (r) between one donor and one acceptor are 39.1 and 43.1 Å for QDs and QRs, respectively, using the efficiency of Förster resonance energy transfer (FRET) which depends on the inverse sixth power of the distance of separations between one nanocrystal and one dye molecule. Considering single donor and multiple acceptors interactions, the calculated average distances (rn) between the donor and acceptor are 47.7 and 53.9 Å for QD's and QR's, respectively. The steady-state and time-resolved spectroscopic analysis of nanoassemblies confirm the formation of one donor and multiple acceptors. [source] Where will pathogen inactivation have the greatest impact?ISBT SCIENCE SERIES: THE INTERNATIONAL JOURNAL OF INTRACELLULAR TRANSPORT, Issue 1 2007T. Hervig Blood safety has always been a major task in transfusion medicine. A strategy to obtain this aim should include donor education, donor selection, and testing of blood donations. Pathogen inactivation adds another level of safety. In the fractionation industry, pathogen inactivation methods are mandatory. Several countries also use pathogen-inactivated plasma , from pools or single donors. Concerning the cellular blood components, there is still no method available for red cell concentrates, whereas methods for platelet concentrates are available in some countries and others are in the pipeline for commercialization. The efficiency of the ,old' methods to increase blood safety and the costs of the methods seem to be major obstacles for the introduction of the systems. There are also concerns on product quality and loss of volume during the inactivation process. As the importance of pathogen inactivation is largest in countries with blood donors who carry infections it is impossible to protect against, either due to high incidence of the infection or due to shortage of tests, cost will be a major question when pathogen inactivation is considered. Pathogen inactivation of red cell concentrates will also be a necessity. When pathogen inactivation methods are available for all blood components, they will have great impact to protect the patients in countries where a high percentage of the population is infected by agents transmissible through blood transfusion, and in all situations to protect against new pathogens and ,old' pathogens that become more virulent. The total risk of contracting infectious diseases through blood transfusion will probably be important when implementation of new methods for pathogen inactivation is considered. [source] |